BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6693051)

  • 1. The prognostic significance of adenomyosis in endometrial carcinoma.
    Hall JB; Young RH; Nelson JH
    Gynecol Oncol; 1984 Jan; 17(1):32-40. PubMed ID: 6693051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma.
    Demopoulos RI; Dubin N; Noumoff J; Blaustein A; Sommers GM
    Obstet Gynecol; 1986 Aug; 68(2):245-50. PubMed ID: 3737041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases.
    Jacques SM; Lawrence WD
    Gynecol Oncol; 1990 Jun; 37(3):401-7. PubMed ID: 2351325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoacanthoma and mixed adenosquamous carcinoma of the endometrium. A clinicopathologic study.
    Silverberg SG; Bolin MG; DeGiorgi LS
    Cancer; 1972 Nov; 30(5):1307-14. PubMed ID: 5083064
    [No Abstract]   [Full Text] [Related]  

  • 5. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
    Carcangiu ML; Chambers JT
    Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus.
    Ambros RA; Kurman RJ
    Cancer; 1992 Mar; 69(6):1424-31. PubMed ID: 1371712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
    Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
    Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
    Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
    Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial adenocarcinoma in Norway. A study of a total population.
    Abeler VM; Kjørstad KE
    Cancer; 1991 Jun; 67(12):3093-103. PubMed ID: 2044053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis.
    Mittal KR; Barwick KW
    Gynecol Oncol; 1993 May; 49(2):197-201. PubMed ID: 8504988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial adenocarcinoma arising in adenomyosis.
    Hernandez E; Woodruff JD
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 1):827-32. PubMed ID: 7446615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of endometrial adenocarcinoma with emphasis on morphologically variant types.
    Liu CT
    Am J Clin Pathol; 1972 May; 57(5):562-73. PubMed ID: 5025600
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment and prognosis of pT2 endometrial carcinoma].
    Tamura H; Nakai Y; Nagano T; Ohara A; Shibamoto T; Nakayama T; Ohnishi T; Wakutani K; Taniguchi F; Suzuki N
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):315-20. PubMed ID: 2045699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic importance of steroid receptors in endometrial carcinoma.
    Palmer DC; Muir IM; Alexander AI; Cauchi M; Bennett RC; Quinn MA
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):388-93. PubMed ID: 3405554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables.
    Hendrickson M; Ross J; Eifel PJ; Cox RS; Martinez A; Kempson R
    Gynecol Oncol; 1982 Jun; 13(3):373-92. PubMed ID: 6284595
    [No Abstract]   [Full Text] [Related]  

  • 16. Adenosquamous carcinoma of the endometrium. An entity with an inherent poor prognosis?
    Salazar OM; DePapp EW; Bonfiglio TA; Feldstein ML; Rubin P; Rudolph JH
    Cancer; 1977 Jul; 40(1):119-30. PubMed ID: 880545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studies of 145 cases of endometrial carcinoma--analysis of prognostic factors, especially pathological types].
    Fukuma K; Tohya T; Souda Y; Fuzisaki S; Maeyama M; Mimori H
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1508-14. PubMed ID: 3772201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
    Nascimento AF; Hirsch MS; Cviko A; Quade BJ; Nucci MR
    Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoepidermoid and adenosquamous carcinoma of the uterus. A clinicopathologic study of 118 cases.
    Julian CG; Daikoku NH; Gillespie A
    Am J Obstet Gynecol; 1977 May; 128(1):106-16. PubMed ID: 851156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A clinicopathologic evaluation of "depth" in cases of endometrial adenocarcinoma].
    Sakamoto A; Hirai Y; Yamauchi K; Masubuchi K; Hasumi K
    Gan No Rinsho; 1990 May; 36(6):711-4. PubMed ID: 2348558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.